Background. Most studies of the dynamics of maternal group B Streptococcus (GBS) colonization have relied on capsular serotyping to define GBS acquisition or loss. Newer molecular methods that distinguish GBS clones may expand our knowledge and influence vaccination strategies. We used multilocus sequence typing (MLST) and GBS capsular gene cluster (cps) genotyping to investigate the dynamics of perinatal GBS colonization.
. PCR and sequencing primers for multilocus sequence typing (MLST) that amplify DNA regions specific for 7 conserved housekeeping genes. MLST GTTGGCTTGAAACACGACT … NOTE. The 7 housekeeping genes were adhP, atr, glcK, glnA, pheS, sdhA, and tkt. All primers were developed on the basis of the NEM316 DNA sequence (CAD45676 [18] ), and the location is relative to the start codon of the gene of interest. Primers are labeled by the gene or locus name and location within the gene in base pairs (bp) from the start codon. F, forward; R, reverse.
frequently causes neonatal disease and has been suggested to have enhanced invasiveness [13] [14] [15] .
PATIENTS AND METHODS

Study population.
A total of 235 GBS strains were recovered from 1207 women who were enrolled in a cohort study that was conducted during the period 1998-2000 in Calgary, Canada, and that was approved by the University of Calgary Ethics Board [4] . Isolates were not available for 23 women. The 1207 pregnant women were enrolled at 35-37 weeks of gestation, completed a questionnaire, and provided a vaginal-rectal swab specimen for GBS culture (visit 1) [4] . A subset of these women ( ) repeated the study protocol at ∼6 weeks postpartum n p 592 (visit 2), as described elsewhere [16] . A total of 338 GBS strains from 212 women who were colonized with GBS during at least 1 of the 2 visits were available for molecular typing (126 of the women who were positive for GBS at both visits yielded 252 strains; 66 women were positive only at visit 1, and 20 were positive only at visit 2). Medical record reviews were conducted after visits 1 and 2 and at the time of delivery.
GBS isolation, cps genotyping, serotyping, and susceptibility testing. DNA isolation and a PCR-based restriction fragment-length polymorphism assay to assign cps genotypes, which predict GBS serotypes, are described elsewhere [17] . Serotyping, performed by the National Center for Streptococcus (Edmonton, Canada), using the Ouchterlony immunodiffusion method with rabbit antisera, is described elsewhere [4] , as are susceptibilities to erythromycin and clindamycin [16] .
MLST. PCR was completed for 7 housekeeping genes that were previously identified [14] using modified primers (table  1) , permitting 1 primer set to be used for both PCR and sequencing. PCR conditions included a 10-min soak at 94ЊC; 35 cycles of 92ЊC for 1 min, at 53ЊC for 1 min, and at 72ЊC for 30 s; and a 5-min soak at 72ЊC. PCR products were purified and sequenced (Applied Biosystems) at the Michigan State University Genomic Research Support Technical Facility (East Lansing, MI). Consensus sequences were trimmed in SeqMan (DNA Star), and allele and ST assignments were made using the MLST database [19, 20] . A neighbor-joining tree was constructed [21] with the concatenated sequence data with use of MEGA3 [22] . Epidemiological analysis. The frequency of GBS molecular characteristics was assessed by visit and colonization dynamics. Colonization at both visits was defined as "persistent" colonization when the same GBS ST was identified at both visits 1 and 2. When the ST differed over time, the women were considered to have acquired a new clone by visit 2 after losing the visit 1 clone. Univariate analyses were performed to identify host and clinical factors associated with colonization status. Logistic regression identified predictors of (1) persistent GBS colonization versus GBS loss and (2) any ST change versus no ST change among women colonized at both visits. Adjusted ORs and 95% CIs were noted. SAS software, version 9.1 (SAS Institute), was used for all analyses.
RESULTS
Study participant characteristics and colonization dynamics.
Of the 212 women in the study, most (143; 67%) were aged Colonization at both visits 1 and 2 occurred in 126 (59%) of the 212 women. Sixty-six women (31%) were colonized with GBS at visit 1 but had lost GBS by visit 2, whereas 20 women (9%) had negative culture results at visit 1 but had acquired GBS by visit 2.
Genetic diversity of colonizing GBS. Application of MLST identified 29 STs among all 338 strains. Seven of the STs were composed of strains with 11 cps genotype (figure 1). Of the 29 STs, 18 from visit 1 and 14 from visit 2 were previously described [20] , whereas another 11 were ST variants (figure 1). STs 1, 23, 19, 12, 17 , and 8 together accounted for 82% of all strains. The 11 ST variants were identified among 17 strains (6 were detected twice in women colonized at both visits). Six variants were related to ST-23 with unique atr ( ), glnA n p 3 ( ), glcK ( ), and pheS ( ) alleles. Another ST n p 2 n p 1 n p 1 was related to ST-19 because of variation in sdhA, and 2 others were related to ST-1 because of a unique combination of previously identified alleles ( ) or variation in glcK ( ). n p 1 n p 1 A unique allele combination was also observed for the ST-3 variant (figure 1).
The frequencies of several STs varied between visits (figure 2). The frequency of ST-12 decreased between visit 1 (20 [10. 4%] of 192 strains) and visit 2 (9 [6.2%] of 146 strains), although the change was not statistically significant, compared with all other STs ( ). The opposite trend was observed P p .17 for the frequencies of STs 8 and 19, which increased from 6.8% to 8.9% and from 13.5% to 15.8%, respectively; neither asso- Figure 2 . Distribution of multilocus sequence types (STs) and frequency of capsule (cps) genotypes among 338 group B Streptococcus strains from 212 women who were colonized during pregnancy (visit 1) and/or at 6-8 weeks after delivery (visit 2). The STs are ranked in order of decreasing overall frequency, and the proportion of some STs differed between visits. STs followed by a "v" represent ST variants; STs 23v and 1v are pooled together because of the high degree of similarity (bootstrap 196% and 179%, respectively) in the phylogenetic analyses. The overall frequency of cps genotypes is noted, because there were no differences in the cps distribution by visit; 2 ST-1 strains had cps5 variant genotypes but were included in the cps5 category.
ciation was statistically significant (figure 2). No differences were observed for any other STs or cps genotypes by visit.
Molecular changes among 126 women colonized at both visits 1 and 2. Comparisons of the ST, cps genotype, and serotype between visits revealed differences in 23 (18%) of 126 women (table 2) , with a change in the colonizing ST occurring most frequently (in 13 women [10%]). Eight women had a different ST, cps genotype, and serotype by visit 2, whereas 5 women had a different ST, but the cps genotype and serotype remained the same (table 2) .
A change in the cps genotype and/or serotype also occurred frequently (in 10 [8%] of 126 women). Five women had typeable strains at visit 1 but nontypeable strains at visit 2; the ST and cps genotype were identical at both visits (table 2) for all but 1 woman, who had a strain that was negative for cps by PCR. Capsular switching, as defined by expression of a different capsule type or a change in the cps genotype among strains with no ST change over time, was observed in 4 women ( for women aged 26-35 years, but the association was not statistically significant (table 4) . Any antibiotic use was associated with a decreased likelihood of persistent colonization (table 4) ; however, women who received only IAP were more likely to have persistent colonization, compared with women who used antibiotics during all other periods ( ). P ! .001
DISCUSSION
Previous studies have used serotyping [2, 5] or PFGE [6] to evaluate GBS changes before and after delivery. Although specific serotypes are associated with neonatal disease [9] [10] [11] , serotyping is not ideal for determining clonality, because of capsular switching [12] [13] [14] and because up to 11% of strains cannot be typed [4] . Similarly, PFGE data classify some serotypes-particularly type V-as identical even though they are not clonal [23] . Using MLST, a more sensitive tool to assess genetic differences, we gained new insights into the characteristics of colonizing GBS strains in association with different host factors. The study of GBS STs and cps genotypes suggests 2 hypothetical models of GBS occurrence and dynamics among Figure 3 . Distribution of multilocus sequence types, stratified by capsule (cps) genotypes, among 212 pregnant women who were colonized with group B Streptococcus (GBS) before (visit 1) and/or after (visit 2) delivery, by colonization dynamic. The sequence types are ranked in order of decreasing overall frequency, with the "others" category comprising all nonpredominant sequence types grouped together. Two women who had persistent colonization with the same GBS sequence type were colonized with different cps genotypes at visits 1 and 2; these cases were included in the lost and acquired distributions because of the cps change.
the 126 women who were colonized before and after delivery. These 2 models are based on the persistence and replacement of certain clones.
Clonal persistence model. In this model, the common GBS clone detected by MLST was constant and isolated at both visits.
Under the clonal persistence model with stable phenotypes, colonizing GBS strains failed to be eradicated, because identical STs and capsular types were detected at both visits. Antibiotic use likely decreases the density of the colonizing GBS clone, but the clone rebounds at treatment cessation. In this study, this model was applicable for most women who received IAP (table 3) and 90% of the women who were colonized with GBS at both visits. The one exception is that some women can be colonized with strains of the same ST over time but have differences in capsular expression with or without a change in the cps genotype (table 2) . In this study, most of the women who had a change only in capsular expression had typeable strains at visit 1 and nontypeable strains at visit 2; the cps genotype was identical in all but 1 woman. Capsule expression changes with and without cps genotype changes (capsular switching) also were observed. In 2 cases, capsule type III expression was documented in a cps1a strain, whereas capsule type Ia expression occurred in a cps3 strain. Because the ST remained the same in both cases, recombination within the cps gene clusterparticularly in cpsH, which was shown to confer serotype specificity in type Ia and III strains [24] -may have been responsible for the altered phenotype. Although we cannot rule out the possibility that either the serotyping or cps genotyping systems erroneously classified the capsule types in these cases, we suspect that such changes do occur in nature and are influenced by antibiotics and host immune factors. Clonal replacement model. In this model, the resident strain was eliminated and replaced by new genotypes after exposure to and colonization with different GBS strains. Under the replacement model, the new resident strain was distinct in ST and capsule type. Because there are only 9 GBS serotypes, there were some cases in which the new ST from visit 2 had the same capsule as the original strain from visit 1. This situation occurred for several GBS strains expressing capsular serotype V; thus, the visit 2 strain would have been classified as identical to the visit 1 strain by serotyping and, possibly, by PFGE because of the homogenous nature of serotype V PFGE patterns [23] . However, the latter could not be directly assessed, because PFGE was not used in this study. Expression of the same capsular type by different clones suggests a survival advantage. This may be related in part to antibiotic pressures or low antibody levels against the capsular type of the colonizing strain [4] . The most common pattern in the clonal replacement model involved a clear change in the ST, cps genotype, and serotype between visits. This was observed in 10% of women who were colonized at both visits and implies that the original colonizing strain was eradicated and replaced with an entirely different clone. In these women, antibiotic use probably enhanced clearance of the original strain, possibly with support of host immune factors, thereby setting the stage for acquisition of new strain types. Replacement is most likely to occur after receipt of a full course of antibiotics. In addition to the persistence and replacement models, complete elimination of the colonizing GBS strain also occurred between visits. Eradication is likely related to antibiotic use, host immune factors, and/or the molecular characteristics of the colonizing strain. In some women, it is also possible that the predominant GBS type was eliminated, allowing other types present in lower, undetectable numbers to reproduce and dominate. These dynamics cannot be distinguished from the persistence and replacement models without more extensive population sampling and additional time points.
In this study, the predominant colonizing clones (STs 1, 23, and 19) were equally represented among women with persistent colonization and women who had lost and acquired GBS ( figure  3 ). This distribution suggests that these clones represent the most common strains in circulation or are well adapted to the vaginal mucosa. Each of the 3 major STs was associated with 1 predominant cps type, although multiple cps types were observed.
Some STs may be more difficult to eradicate by antibiotics in vivo. Strains resistant to either erythromycin or clindamycin did not persist more frequently than susceptible strains in this study. Although we did not examine it, it is possible that tol- erance-and not resistance-to specific antibiotics is important for persistent colonization. This hypothesis is supported by our finding that IAP is associated with persistent colonization. Although antibiotic use at any time between visits contributed to eradication in 65 of the 66 women who lost GBS over time, use of IAP alone, compared with antibiotic use at any other time between visits, was associated with persistent colonization. This was probably attributable to the fact that IAP was given in 1 or 2 doses before delivery, whereas other antibiotics administered to treat infections before or after delivery were given for longer durations. This is consistent with prior studies demonstrating that short exposure to IAP penicillin is ineffective for eliminating GBS entirely; instead, it merely decreases the bacterial density [25, 26] .
Host clearance mechanisms may also play a role in eradicating some-but not all-STs. For example, phenotypic factors that facilitate colonization could render some clones less effective at gaining entry into the bloodstream or CSF (i.e., invasion), resulting in neonatal disease. Strains of STs 1, 23, and 19 have been suggested [15] to be poor at invasion, although some members of each ST contribute to neonatal disease. In contrast, ST-17 strains have been suggested to exhibit an enhanced ability to cause invasive neonatal disease [13] [14] [15] and may not be as well suited for colonization. This is supported by the observation that ST-17 strains are closely related to strains of bovine origin [15] ; thus, their ability to adapt to the human host may be decreased. ST-17 strains also only express serotype III [12, 14, 15] , which is associated with lower maternal antibody levels and reduced neonatal protection [12] . We hypothesize that GBS with the type III capsule represents STs that are more difficult to eradicate; type III ST-19 and ST-17 strains combined were more likely to persist, compared with all other STs and all type III strains of different STs. This finding may partly explain why type III strains more frequently cause lateonset neonatal disease [27] and why late-onset disease frequencies have remained unchanged since the implementation of IAP protocols [28] .
In the same way, some STs are likely to be more easily eradicated than others. ST-12 strains, for example, were overrepresented in women who lost GBS by the second visit. We speculate that ST-12 strains, particularly those with the cps2 genotype, are more susceptible in vivo to the antibiotics used during pregnancy. Supporting evidence for this includes the larger decrease in frequency of ST-12 strains by visit 2, compared with other STs, and the fact that capsule type II strains in general infrequently cause neonatal GBS disease [10, 27] . The latter observation may be related to enhanced clearance by IAP or other perinatal antibiotic use.
An interesting association also was identified between colonization dynamics and age. Although younger women were more likely to be colonized with GBS [4, 29] , once colonization occurred, older women were more likely to have persistent colonization with the same GBS clone. This suggests that established clones colonizing older women represent GBS types to which these women have failed to develop immunity. This finding is corroborated by previous reports showing that older patients colonized with serotype V lack antibodies to capsular type V [30] . Consequently, the age of the patient may warrant consideration when evaluating GBS vaccination policies aiming to prevent neonatal disease.
Our study has 2 main limitations. First, GBS colonization was examined at only 2 time points. Therefore, we may have missed additional ST changes at interim time points. Although it would have been ideal to examine additional time points, the basic tenets of our observations and theories of colonization were likely to have remained unchanged. Second, this study was not designed to examine factors associated with GBS acquisition, including sexual activity [8, 31] and dietary history [32] , that may influence colonization by specific clones.
In conclusion, ST-based genotyping of GBS provided fundamental insights into the nature of maternal colonization in the context of IAP, the current cornerstone for preventing neonatal GBS disease. By characterizing GBS clones from women before and after delivery, we were able to propose colonization models and identify clones that are more likely to persist and be eradicated. In addition, we determined that IAP and older age are associated with persistent GBS colonization. These findings may prove to be useful for the future development of GBS vaccines and early-and late-onset neonatal disease-prevention programs.
